Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Marksans Pharma Ltd. AGM Information 2023

Aug 28, 2023

62142_rns_2023-08-28_13a08475-38aa-4cbf-bdd2-8e1fd7d76156.pdf

AGM Information

Open in viewer

Opens in your device viewer

==> picture [47 x 46] intentionally omitted <==

==> picture [86 x 18] intentionally omitted <==

==> picture [111 x 18] intentionally omitted <==

Date : 28[th] August, 2023

BSE Limited

Corporate Relation Department Phiroze Jeejeeboi Towers, Dalal Street, Mumbai – 400001. Scrip Code: 524404

National Stock Exchange of India Limited Listing Department Exchange Plaza, C-1, Block-G, Bandra-Kurla Complex, Bandra (East), Mumbai – 400051. Symbol: MARKSANS

Dear Sir/Madam,

Sub: Proceedings of the 31[st] AGM of Marksans Pharma Limited

Pursuant to Regulation 30 read with Part-A of Schedule-III of SEBI (Listing Obligations and Disclosures Requirements), 2015, kindly find enclosed herewith proceedings of the 31[st] Annual General Meeting of Marksans Pharma Limited held today i.e. Monday, 28[th] August, 2023 at 04:30 P.M. through Video Conferencing /Other Audio Visual means.

We request you to take the aforesaid on records.

Thanking You.

Yours faithfully, For Marksans Pharma Limited

HARSHAVARDH Digitally signed by HARSHAVARDHAN PANIGRAHI AN PANIGRAHI Date: 2023.08.28 17:28:52 +05'30'

Harshavardhan Panigrahi Company Secretary

Encl: As Above

==> picture [6 x 74] intentionally omitted <==

==> picture [72 x 15] intentionally omitted <==

==> picture [93 x 15] intentionally omitted <==

==> picture [431 x 33] intentionally omitted <==

==> picture [47 x 46] intentionally omitted <==

==> picture [86 x 18] intentionally omitted <==

==> picture [111 x 18] intentionally omitted <==

Summary of proceedings of the 31[st] Annual General Meeting of Marksans Pharma Limited held on Monday, 28[th] August, 2023 at 04:30 PM through Video Conferencing / Other Audio Visual means (VC)

This is to inform you that the 31[st] Annual General Meeting (“AGM”) of Marksans Pharma Limited (“the Company”) was held today i.e. Monday, 28[th] August, 2023 at 04:30 P.M. through VC and the businesses mentioned in the Notice dated August 01, 2023 were transacted.

1. Date, Time and Venue of the Meeting:

The AGM of the Members of the Company was held on Monday, 28[th] August, 2023 at 04:30 p.m. through Video Conferencing / Other Audio Visual means (VC). For the purpose of recording the proceedings, the AGM was deemed to have been held at the registered office of the Company at 11[th] Floor, Grandeur, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai, India.

2. Brief details of the items deliberated at the meeting and the results thereof:

  • a. Mr. Mark Saldanha, Chairman chaired the proceedings of the meeting.

  • b. Mr. Harshavardhan Panigrahi, Company Secretary explained the procedure for conducting the meeting through VC as well as voting during the AGM.

  • c. The Chairman informed that all the Directors of the Company & Mr. Jitendra Sharma, Chief Financial Officer had joined the meeting from their respective locations. The Chairman further informed that Mr. Digant Mahesh Parikh, Chairman of the Audit Committee and Mr. S. R. Buddharaju, Chairman of the Stakeholder Relationship Committee and the Nomination and Remuneration Committee attended the AGM from their respective locations. The Chairman further informed that authorised representative of Statutory Auditor, Secretarial Auditor and Scrutinizer had also joined the meeting from their respective locations.

  • d. The requisite quorum being present, the Chairman called the meeting to order.

  • e. The Chairman informed that the meeting is being held through VC in accordance with the provisions of Companies Act, 2013, circulars issued by the Ministry of Corporate Affairs and SEBI.

  • f. With the consent of the members, the Notice convening the 31[st] AGM and the Auditor's Report were taken as read.

  • g. The Chairman then delivered his speech.

==> picture [6 x 74] intentionally omitted <==

==> picture [72 x 15] intentionally omitted <==

==> picture [93 x 15] intentionally omitted <==

==> picture [431 x 33] intentionally omitted <==

==> picture [47 x 46] intentionally omitted <==

==> picture [86 x 18] intentionally omitted <==

==> picture [111 x 18] intentionally omitted <==

  • h. The Company Secretary informed that the Board had appointed Mr. Jinesh Dedhia, Practicing Company Secretary, to act as the Scrutinizer to scrutinize the remote e- voting and the votes cast at the meeting in a fair and transparent manner and to provide a consolidated report thereof.

  • i. The Company Secretary informed that Members who did not vote earlier through remote e-voting may vote electronically during the course of the meeting.

  • j. The Company Secretary then called the names of those Shareholders who had registered themselves to speak or ask questions pertaining to the performance of the Company during the Financial Year 2022-23, one by one.

  • k. Clarifications were provided by the Chairman to the queries raised by the members at the meeting.

  • l. The Company Secretary informed that results of voting would be announced on or before 30[th] August, 2023 by intimation to the Stock Exchanges and would also be placed on the website of the Company www.marksanspharma.com.

  • m. The Chairman then thanked the Members for their co-operation and declared the Meeting as closed.

  • n. The following items of Ordinary and Special business as per the Notice of AGM dated August 01, 2023, were transacted through remote e-voting and through e- voting during the AGM:

Ordinary Business

  • Adoption of the Standalone and Consolidated Audited Financial Statements of the Company for the financial year ended 31[st] March, 2023 together with the reports of the Board of Directors’ and the Auditors’ thereon.

  • Ratification of payment of dividend of Rs. 0.50 (i.e. 50%) on Equity Shares of Re. 1/- each face value.

  • Approval of re-appointment of Dr. Sunny Sharma (DIN: 02267273) who retired by rotation and being eligible, offered himself for re-appointment.

==> picture [6 x 74] intentionally omitted <==

==> picture [72 x 15] intentionally omitted <==

==> picture [93 x 15] intentionally omitted <==

==> picture [431 x 33] intentionally omitted <==

==> picture [47 x 46] intentionally omitted <==

==> picture [86 x 18] intentionally omitted <==

==> picture [111 x 18] intentionally omitted <==

Special Business

  • Approval of appointment of Mrs. Shailaja Vardhan (DIN: 10172764) as an Independent Director of the Company.

  • Approval of re-appointment of and remuneration to Mrs. Sandra Saldanha (DIN: 00021023) as a Whole-time Director for a period of Three (3) years with effect from 25[th] September, 2023.

  • Approval of amendment and restatement of the Articles of Association of the Company

  • Approval of Marksans Employees Stock Option Scheme 2023.

3. Manner of approval:

  • Pursuant to the provisions of the Companies Act, 2013 and Regulation 44 of the SEBI (Listing Obligations and Disclosures Requirements), 2015, the Company had provided remote e-voting facility to its members to cast their votes electronically, on all the resolutions set out in the notice.

  • Further, the facility for remote e-voting was also made available during the AGM to the members who were present at the AGM and had not cast their votes by remote e-voting earlier.

The meeting concluded at 05:11 p.m. on the same day with a vote of thanks to the Chair.

==> picture [6 x 74] intentionally omitted <==

==> picture [72 x 15] intentionally omitted <==

==> picture [93 x 15] intentionally omitted <==

==> picture [431 x 33] intentionally omitted <==